Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

ConditionLymphoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital

About this trial

The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

English speaking adult (18 years or older at enrollment)

Is at least 6 months post-diagnosis and a) is currently undergoing lymphoma treatment (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other) with evidence of treatment response or disease control; or b) has completed lymphoma treatment (e.g., chemotherapy/immunotherapy/radiation therapy, surgery or other) within the past 2 years and has disease control at treatment completion; patients may still be on maintenance treatment to prolong disease control.

Disqualifiers

Has not initiated treatment for lymphoma.

Has worsening, progressive, or uncontrolled disease that is not responding to treatment.

Active Psychiatric, medical or cognitive comorbidity as determined by site PI or treating clinician

Unwilling or unable to participate using telehealth platform

Trial design

Design model

Parallel

Treatments tested in this trial

  • Enhanced Usual Care

    Other intervention

    Participants will receive a singleevaluation with a site social worker along with a list of mental health, social or community resources . This most closely resembles the real-world care available to survivors on an outpatient basis, however, we call this enhanced usual care since proactive identification and referral of posttreatment survivors is not routinely done.

  • SMART3RP-Lymphoma

    Other intervention

    The intervention components include: 1. Eliciting the relaxation response (RR) involves sustained mental focus with an attitude of open receptive awareness. 2. CBT to improve stress management involves increasing awareness and identification of the components of one's stress response (negative thoughts, emotions, physical reactions, behaviors, and relational) and learning skills at each session to alter these components (e.g., cognitive restructuring). 3. Positive psychology strategies to achieve growth enhancement focus on utilizing techniques and skills to promote positive growth. Skills focus on increasing social support, positive affect, and compassion.

Treatment groups

254 Participants
are divided into 2 treatment groups
Group A: Enhanced Usual CareOther 1 intervention
Group B: SMART3RP-LymphomaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change from Baseline in Coping Scores on the Measure of Current Status Scale (MOCS-A)

The Measure of Current Status Scale (MOCS-A) measures coping processes on 4 domains: ability to relax, recognize stress, elicit support, and restructure thoughts. It is a 13-item scale where each item is measured on a 0-4 scale.

Time frame
Baseline to 3 month follow up

Secondary outcomes

1

Change in Anxiety Symptoms Based on the Generalized Anxiety Disorder Scale-7 (GAD-7)

The Generalized Anxiety Disorder Scale-7 (GAD-7) is a 7-item self-report measure assessing symptoms of anxiety. Items are rated on a 0 to 3 scale and summed to produce a total score ranging from 0 to 21. Higher scores indicate greater anxiety symptom severity.

Time frame
Enrollment to 3 month follow up
2

Change in Depressive Symptoms Based on the Patient Health Questionnaire-8 (PHQ-8)

The Patient Health Questionnaire-8 (PHQ-8) is an 8-item self-report measure assessing symptoms of depression. Items are rated on a 0 to 3 scale and summed to produce a total score ranging from 0 to 24. Higher scores indicate greater depressive symptom severity.

Time frame
Enrollment to 3 month follow up
3

Change in Physical Health (PROMIS Physical Function-8b)

The PROMIS Physical Function-8b is an 8-item measure that assesses the ability to perform daily living activities. Each item is scored on a scale of 1 (Unable to do) to 5 (Without any difficulty).

Time frame
Enrollment to 3 month follow up
4

Change in Quality of Life Based on the Functional Assessment of Cancer Therapy-General (FACT-G)

The Functional Assessment of Cancer Therapy-General (FACT-G) is a 27-item self-report measure assessing overall quality of life across four domains: physical well-being, functional well-being, emotional well-being, and social/family well-being. Items are rated on a 0 (not at all) to 4 (very much) scale and summed to produce a total score ranging from 0 to 108. Higher scores indicate better quality of life.

Time frame
Enrollment to 3 month follow up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.